"We wanted to go out big and we did," the highest scorer in Bradley Central Bearette history proclaimed after sizzlin' the strings for 42 points in her final game at ...

"We wanted to go out big and we did," the highest scorer in Bradley Central Bearette history proclaimed after sizzlin' the strings for 42 points in her final game at ...

Ripping the cords for 42 points, reigning Miss Tennessee Basketball Kimora Fields not only ascended to the top of the all-time Bradley Central Bearette scoring ranks, but secured a fourth straight ...

Ella Huber scored 1:33 into overtime as the Boston Fleet beat the Montréal Victoire 4-3 in a first-place showdown in Professional Women's Hockey League action at Place Bell on Sunday afternoon in ...

Viral mismatch between circulating strains and vaccine may have weighed down effectiveness ...

As the U.S. flu season winds down, health officials say the flu vaccine didn’t work very well. It had one of its worst effectiveness rates in more than a decade.

WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of ...

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will ...

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology. By Christina Jewett and ...

Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...

Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he’s suggested it’s personal. Kennedy has linked his strained, raspy speech to the vaccine, ...

The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said ...